henhaobio
Sign in

Frontiers in Integrative NeuroscienceNeurosciencePeer-reviewed journal article

Cannabis use is associated with sexually dimorphic changes in executive control of visuospatial decision-making

Parker J. BanksiD, Patrick BennettiD, Allison B. SekuleriD, Aaron J. GruberiD

PDFDOIPreprint

Abstract

When the outcome of a choice is less favourable than expected, humans and animals typically shift to an alternate choice option. Several lines of evidence indicate that this "lose-shift" responding is an innate sensorimotor response strategy that is normally suppressed by executive function. Therefore, the lose-shift response provides a covert gauge of cognitive control over choice mechanisms. We report here that the spatial position, rather than visual features, of choice targets drives the lose-shift effect. Furthermore, the ability to inhibit lose-shift responding to gain reward is different among male and female habitual cannabis users. Increased self-reported cannabis use was concordant with suppressed response flexibility and an increased tendency to lose-shift in women, which reduced performance in a choice task in which random responding is the optimal strategy. On the other hand, increased cannabis use in men was concordant with reduced reliance on spatial cues during decision-making, and had no impact on the number of correct responses. These data (63,600 trials from 106 participants) provide strong evidence that spatial-motor processing is an important component of economic decision-making, and that its governance by executive systems is different in men and women who use cannabis frequently.

Citations
2
FWCI
0.30
Field percentile
top 49%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISZimmermann '19Kluwe‐Schia '19Mason '19Zhao '19Faraji '25Hynes '23
66% semantic matchNeuroscience
Kaeli Zimmermann, Keith Maurice Kendrick, Dirk Scheele+7 more·European Neuropsychopharmacology·Jan 15, 2019· 27 citations